Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $4.15B | $4.56B | $5.24B | $6.06B |
| Revenue growth | — | 9.9% | 14.8% | 15.8% |
| Operating income | $263M | $337M | $403M | $551M |
| Operating margin | 6.3% | 7.4% | 7.7% | 9.1% |
| Net income | -$21.0M | -$35.1M | $11.0M | $277M |
| Net margin | -0.5% | -0.8% | 0.2% | 4.6% |
| EPS (diluted) | -$0.08 | -$0.13 | $0.04 | $0.83 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | $27.3M | $67.9M | $76.3M | $317M |
| Capital expenditures | $41.2M | $55.1M | $103M | $82.4M |
| Free cash flow | -$14.0M | $12.8M | -$26.6M | $234M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $120M | $58.0M | $103M | $290M |
| Total assets | — | $5.76B | $6.21B | $6.56B |
| Total liabilities | — | $4.61B | $3.84B | $3.89B |
| Long-term debt | — | $3.17B | $2.21B | $2.19B |
| Shareholders' equity | $1.20B | $1.15B | $2.37B | $2.67B |
| Retained earnings | — | -$1.57B | -$1.56B | -$1.29B |
| Shares (wtd avg diluted) | 275M | 275M | 290M | 334M |
Every figure is extracted from StandardAero, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.